Copper Dysregulation in Major Depression: A Systematic Review and Meta-Analytic Evidence for a Putative Trait Marker

Area of Science:

• Neurobiology
• Biochemistry
• Psychiatry

Background:

• Major depressive disorder (MDD) is a significant cause of global disability.
• Current diagnostic and monitoring methods for MDD lack reliable peripheral biomarkers.
• Copper (Cu) is an essential trace element implicated in redox balance and neurotransmitter metabolism, with inconsistent associations reported for MDD.

Purpose of the Study:

• To systematically evaluate and quantify serum copper concentrations in individuals with MDD compared to healthy controls.
• To investigate potential moderators of the Cu-MDD association, such as sex, age, and analytical methods.

Main Methods:

• A systematic review and meta-analysis of observational studies was conducted.
• Data from 24 studies involving 8617 participants (2736 MDD, 5881 controls) were analyzed.
• Subgroup and sensitivity analyses were performed to explore heterogeneity and robustness.

Main Results:

• Pooled analysis revealed significantly higher serum copper levels in MDD patients (Mean Difference = 2.22 µmol/L, p=0.001).
• Elevated copper levels were also observed in subgroup analyses of females (Mean Difference = 1.39 µmol/L, p=0.009).
• High heterogeneity (I² = 98.6%) was noted, but results were robust in sensitivity analyses, and publication bias was not indicated.

Conclusions:

• The study supports an association between altered copper homeostasis and MDD.
• Elevated serum copper may represent a potential trait biomarker for MDD, observed across various subgroups.
• Further research with standardized measurements and longitudinal designs is necessary to confirm clinical utility.